US Patent Issued to ELI LILLY and Co. on June 2 for "Dose regimens for use of LY3154207 in the treatment of dopaminergic CNS disorders" (Indiana Inventors)

ALEXANDRIA, Va., June 2 -- United States Patent no. 12,642,794, issued on June 2, was assigned to ELI LILLY AND COMPANY (Indianapolis). "Dose regimens for use of LY3154207 in the treatment of dopamin... Read More

US Patent Issued to The University of Hong Kong on June 2 for "MRGPRX2 antagonist for the treatment of pseudo allergic reactions" (Chinese Inventors)

ALEXANDRIA, Va., June 2 -- United States Patent no. 12,642,795, issued on June 2, was assigned to The University of Hong Kong (Hong Kong). "MRGPRX2 antagonist for the treatment of pseudo allergic rea... Read More

US Patent Issued to Avior on June 2 for "Method and device of treating chronic kidney disease-associated pruritus" (North Carolina Inventor)

ALEXANDRIA, Va., June 2 -- United States Patent no. 12,642,796, issued on June 2, was assigned to Avior Inc. (Cary, N.C.). "Method and device of treating chronic kidney disease-associated pruritus" w... Read More

US Patent Issued to Seasons Biotechnology (Taizhou) on June 2 for "Coated granule, solid dispersion, and preparation containing vortioxetine hydrobromide for oral taste masking" (Chinese Inventors)

ALEXANDRIA, Va., June 2 -- United States Patent no. 12,642,797, issued on June 2, was assigned to Seasons Biotechnology (Taizhou) Co. Ltd. (Zhejiang, China). "Coated granule, solid dispersion, and pr... Read More

US Patent Issued to Alkermes Pharma Ireland on June 2 for "Aripiprazole prodrug composition" (Irish, American Inventors)

ALEXANDRIA, Va., June 2 -- United States Patent no. 12,642,798, issued on June 2, was assigned to Alkermes Pharma Ireland Ltd. (Dublin). "Aripiprazole prodrug composition" was invented by Philip Cres... Read More

US Patent Issued to University of South Florida on June 2 for "Composition and method for treating COVID-19" (Florida Inventors)

ALEXANDRIA, Va., June 2 -- United States Patent no. 12,642,799, issued on June 2, was assigned to University of South Florida (Tampa, Fla.). "Composition and method for treating COVID-19" was invente... Read More

US Patent Issued to NICOX on June 2 for "Nitric oxide releasing phosphodiesterase type 5 inhibitor" (Italian Inventors)

ALEXANDRIA, Va., June 2 -- United States Patent no. 12,642,800, issued on June 2, was assigned to NICOX SA (Sophia Antipolis, France). "Nitric oxide releasing phosphodiesterase type 5 inhibitor" was ... Read More

US Patent Issued to SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION on June 2 for "Pharmaceutical composition for preventing or treating rheumatoid arthritis and health functional food" (South Korean Inventors)

ALEXANDRIA, Va., June 2 -- United States Patent no. 12,642,801, issued on June 2, was assigned to SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION (Seoul, South Korea). "Pharmaceutical composition for preve... Read More

US Patent Issued to Incyte on June 2 for "Topical formulations of ruxolitinib with an organic amine pH adjusting agent for treatment of skin diseases" (British, American Inventors)

ALEXANDRIA, Va., June 2 -- United States Patent no. 12,642,802, issued on June 2, was assigned to Incyte Corp. (Wilmington, Del.). "Topical formulations of ruxolitinib with an organic amine pH adjust... Read More

US Patent Issued to PFIZER on June 2 for "Pharmaceutical aqueous formulation comprising 1-(4-{[4-(dimethylamino)piperidin-1-ylcarbonyl}phenyl)-3-[4-(4,6-dimorpholin-4-yl-1,3,5-triazin-2-yl)phenyljurea" (British Inventors)

ALEXANDRIA, Va., June 2 -- United States Patent no. 12,642,803, issued on June 2, was assigned to PFIZER INC. (New York). "Pharmaceutical aqueous formulation comprising 1-(4-{[4-(dimethylamino)piperi... Read More

• ««
• «
• 74522
• 74523
• 74524
• 74525
• 74526
• 74527
• 74528
• 74529
• 74530
• 74531
• »
• »»